Immediate Impact

18 by Nobel laureates 22 from Science/Nature 69 standout
Sub-graph 1 of 23

Citing Papers

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
2023 Standout
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)
2023 Standout
4 intermediate papers

Works of Edith J. Enyedy being referenced

Abnormal expression of various molecular forms and distribution of T cell receptor ? chain in patients with systemic lupus erythematosus
2002
Fc? receptor type I ? chain replaces the deficient T cell receptor ? chain in T cells of patients with systemic lupus erythematosus
2001

Author Peers

Author Last Decade Papers Cites
Edith J. Enyedy 403 214 98 98 16 523
Dania Rabah 330 235 85 141 17 537
M. Yanagida 523 78 38 161 12 616
Tammy P. Cheng 282 61 30 133 12 513
Johanna Stéen 161 180 186 188 23 508
Kusuki Nishioka 190 184 35 237 12 519
Julie A. Di Paolo 162 139 55 99 17 494
Michelle Campbell 356 39 182 197 12 608
Julie Blasioli 444 30 51 223 12 571
Thomas A. Zanardi 112 75 71 277 12 479
M.C. Conroy 205 61 50 88 27 564

All Works

Loading papers...

Rankless by CCL
2026